Cancer Drug Co. Investors Get First OK On $7M Deal
By Sydney Price ( June 23, 2026, 7:55 PM EDT) -- A New York federal judge preliminarily approved a $7 million deal resolving class action claims alleging Spectrum Pharmaceuticals Inc. overstated its regulatory prospects for winning approval for a cancer treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.